STML — STEMLINE THERAPEUTICS INC

Ownership history in Clearline Capital LP  ·  5 quarters on record

This page tracks every 13F SEC filing in which Clearline Capital LP reported a position in STEMLINE THERAPEUTICS INC (STML). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
3.4% (2020 Q1)
Avg. % of fund
1.85%
First filed
2019 Q1
Last filed
2020 Q1
Quarters held
5
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2020 Q1 ADDED 1,519,843 +1,067,714 +236.2% 3.40% $7.4M —
2019 Q4 ADDED 452,129 +145,364 +47.4% 2.06% $4.8M —
2019 Q3 ADDED 306,765 +154,924 +102.0% 1.45% $3.2M —
2019 Q2 REDUCED 151,841 -27,239 -15.2% 1.14% $2.3M —
2019 Q1 INITIATED 179,080 — — 1.20% $2.3M —
% of Fund (quarterly)

Other funds also holding STML

As of 2020 Q1 — sorted by position size

Stonepine Capital Management, LLC 3Y 7Y 4.54% Rubric Capital Management LP 3Y 7Y 2.56% Bullseye Asset Management LLC 3Y 1.08% EVENTIDE ASSET MANAGEMENT, LLC 3Y 7Y 0.65% Rhenman & Partners Asset Management AB 3Y 7Y 0.44% Empire Life Investments Inc. 3Y 7Y 0.42% Schonfeld Strategic Advisors LLC 3Y 7Y 0.29% Leap Investments LP 0.27% VIRTUS ADVISERS, LLC 3Y 7Y 0.12% FARALLON CAPITAL MANAGEMENT LLC 3Y 7Y 0.1%
← Back to Clearline Capital LP Holdings